VLDLR and liver cancer: PN, an MC-derived ingredient, reduces lipid accumulation in the livers of high-fat diet-induced diabetic mice and improves glucose and lipid metabolism by increasing the phosphorylation level of Akt and expression of glucokinase and low-density lipoprotein receptor in human liver cancer-derived HepG2 cells [29].